Identification of drugs associated with reduced severity of COVID-19 – a case-control study in a large population

Mostrar otras versiones (1)

BACKGROUND: Until coronavirus disease 2019 (COVID-19) drugs specifically developed to treat COVID-19 become more widely accessible, it is crucial to identify whether existing medications have a protective effect against severe disease. Toward this objective, we conducted a large population study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Israel, Ariel, Schäffer, Alejandro A, Cicurel, Assi, Cheng, Kuoyuan, Sinha, Sanju, Schiff, Eyal, Feldhamer, Ilan, Tal, Ameer, Lavie, Gil, Ruppin, Eytan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Epidemiology and Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321549/
https://www.ncbi.nlm.nih.gov/pubmed/34313216
http://dx.doi.org/10.7554/eLife.68165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321549/
https://www.ncbi.nlm.nih.gov/pubmed/34313216
http://dx.doi.org/10.7554/eLife.68165

Ejemplares similares